Read More

Candel Therapeutics Announces Late-breaking Oral Presentation At SITC Annual Meeting With Data On CAN-2409 In Combination With Nivolumab In A Phase 1 Mechanistic Clinical Trial In Patients With High-grade Glioma

Combination of nivolumab and CAN-2409 delivered during neurosurgery was generally well tolerated with no significant added toxicity compared to standard of care Systemic immune activation was observed in peripheral

CADL

Read More

AstraZeneca’s Imfinzi (Durvalumab) In Combination With Imjudo (Tremelimumab) Plus Platinum-based Chemotherapy Has Been Approved By The Us Fda For The Treatment Of Adult Patients With Stage Iv (Metastatic) Non-small Cell Lung Cancer

AstraZeneca's Imfinzi (durvalumab) in combination with Imjudo (tremelimumab) plus platinum-based chemotherapy has been approved in the US for the treatment of adult patients with Stage IV (metastatic) non-small cell lung cancer (NSCLC).

AZN

Read More

‘China Trims Covid Quarantine Time By Two Days; Instead Of Having To Stay At A Centralized Quarantine Facility For Seven Days, The New Rules Stipulate A Five Day Quarantine, Followed By Three Days Of Home Observation, According To State Media’ – CNBC

China trims Covid quarantine time by two days (cnbc.com) China reduced the quarantine time for international travelers by two days, state media said Friday. Instead of having to stay at a centralized quarantine

FXI